1 active not recruiting, 1 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 1, Completed 1 |
Follow HEPATITIS C VIRUS CHRONIC INFECTION: new trials by email Literature Review of HEPATITIS C VIRUS CHRONIC INFECTION trials Research Report on HEPATITIS C VIRUS CHRONIC INFECTION
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV Bemnifosbuvir-Ruzasvir, Sofosbuvir-Velpatasvir - HEPATITIS C VIRUS CHRONIC INFECTION, Hepatitis C, Chronic | Phase 3 | Active not recruiting | Atea Pharmaceuticals, Inc. | 880 | 2025-06-02 | 2026-06-29 |
| C-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCV Bemnifosbuvir-Ruzasvir (BEM/RZR), Sofosbuvir-Velpatasvir (SOF/VEL) - HEPATITIS C VIRUS CHRONIC INFECTION | Phase 3 | Completed | Atea Pharmaceuticals, Inc. | 940 | 2025-04-07 | 2026-10-29 |
Hepatitis C (1) · Hepatitis C, Chronic (1)
Blood-Borne Infections (1) · Chronic Disease (1) · Communicable Diseases (1) · Digestive System Diseases (1) · Disease Attributes (1) · Flaviviridae Infections (1) · Hepatitis (1) · Hepatitis, Chronic (1) · Hepatitis, Viral, Human (1) · Infections (1) · Liver Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · RNA Virus Infections (1) · Virus Diseases (1)
sofosbuvir-velpatasvir drug combination (2)
Atea Pharmaceuticals, Inc. (2)
Canada (1) · Egypt (1) · France (1) · Germany (1) · Greece (1) · India (1) · Malaysia (1) · Moldova (1) · Pakistan (1) · Poland (1) · Romania (1) · South Africa (1) · South Korea (1) · Spain (1) · Thailand (1)